Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label, Non-interventional Study to Assess the Safety and Tolerability of Dimolegin® as a Means of Preventing Thrombotic Complications in the Complex Therapy of Hospitalized Patients With Moderate COVID-19 in a Real Clinical Practice

NCT07134738 is registered in ClinicalTrials.gov with Avexima Diol LLC as lead sponsor.

NCT NCT07134738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07134738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label, Non-interventional Study to Assess the Safety and Tolerability of Dimolegin® as a Means of Preventing Thrombotic Complications in the Complex Therapy of Hospitalized Patients With Moderate COVID-19 in a Real Clinical Practice
Lead sponsor
Avexima Diol LLC
Phase
Observational
Overall status
Completed
Start date
June 7, 2024
Completion date
January 15, 2025
Enrollment
184 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19